• Study on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Czechia Estonia France Germany Hungary Italy +3
  • Study on Insulin Aspart, Salbutamol, and Glucose for Treating Acute Hyperkalemia in Emergency Department Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    France
  • Study on Low-Dose Aldesleukin and Ciclosporin for Patients with Newly Diagnosed Type 1 Diabetes Retaining Insulin Secretion

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on Venetoclax, Azacitidine, and Cusatuzumab for Newly Diagnosed Acute Myeloid Leukemia Patients Not Suitable for Intensive Therapy

    Not recruiting

    2 1 1 1
    Germany Spain
  • Study of Atezolizumab and Tiragolumab for Patients with Unresectable Esophageal Squamous Cell Carcinoma After Chemoradiotherapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium France Germany Greece Italy +3
  • Study on Methotrexate and Phototherapy for Adults with Progressive Vitiligo

    Not recruiting

    2 1 1
    Investigated Diseases:
    France
  • Study of Belimumab with Rituximab and Venetoclax for Patients with Refractory or Relapsed Chronic Lymphocytic Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study on the Effects of Cardiodoron Dilution for Patients with Functional Cardiovascular Disorders

    Not recruiting

    3 1 1
    Germany
  • Study on Nivolumab with Paclitaxel and Carboplatin for Early Stage Triple Negative Breast Cancer Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study of Acalabrutinib and Tafasitamab for Patients with Previously Treated Marginal Zone Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Italy

powered by